Skip to main content
. 2014 Jan 30;9(1):e87374. doi: 10.1371/journal.pone.0087374

Table 3. Changes of mRNA abundance (Mean ± SEM ΔΔCt1) of immune factors in bMEC stimulated with six heat-inactivated S. aureus strains for 1, 6, or 24 h.

SLAT(+)3 SLAT(−)3 Analysis of variance (P-value)
Gene2 Time (h) 692 1130 1989 1586 1904 2071 Strain(Type) Cow Strain*Cow
IL-1β 1 0.5±0.3 ac 1.6±0.2 b * 1.3±0.3 bc * 1.3±0.5 bc * 1.5±0.4 b * 0.5±0.3 a 0.01 <0.01 0.03
6 8.3±0.2 a * 8.7±0.2 a * 8.3±0.3 a * 3.5±0.1 b * 5.7±0.5 c * 5.3±0.2 c * <0.01 <0.01 0.01
24 5.1±0.3 ab * 5.7±0.2 b * 4.8±0.1 a * 0.4±0.4 c 1.8±0.3 d * 1.6±0.3 d * <0.01 <0.01 0.03
TNF-α 1 0.7±0.2 a 0.8±0.1 a 0.3±0.3 a 0.2±0.6 ab 05±0.5 a −0.6±0.3 b 0.07 <0.01 0.02
6 5.4±0.4 a * 5.1±0.2 a * 5.1±0.4 a * 1.3±0.6 b * 3.4±0.3 c * 2.9±0.4 c * <0.01 <0.01 0.75
24 4.1±0.2 a * 4.3±0.2 a * 4.1±0.1 a * 1.1±0.2 b * 2.0±0.4 c * 1.6±0.1 bc * 0.11 0.06 0.23
IL-8 1 2.0±0.5 a * 2.1±0.4 a * 1.5±0.2 ab * 0.6±0.4 b 0.8±0.3 b 0.9±0.5 b 0.73 <0.01 0.07
6 7.8±0.2 a * 7.1±0.2 b * 7.0±0.4 b * 4.7±0.1 c * 6.1±0.3 d * 5.4±0.3 e * <0.01 <0.01 0.01
24 7.1±0.3 a * 7.0±0.2 a * 7.1±0.1 a * 3.5±0.4 b * 4.8±0.2 c * 4.1±0.6 c * <0.01 <0.01 0.01
RANTES 1 −0.2±0.2 ab −0.6±0.3 ab 0.1±0.5 a −0.6±0.4 ab −0.5±0.4 ab −0.8±0.5 b 0.56 <0.01 0.72
6 3.9±0.2 a * 4.3±0.2 a * 2.9±0.3 b * 0.0±0.2 c 1.8±0.4 d * 1.0±0.3 e * <0.01 <0.01 0.69
24 3.2±0.3 a * 4.0±0.3 b * 3.0±0.3 a * −0.1±0.5 c 1.1±0.2 d * 0.6±0.4 d <0.01 <0.01 0.06
SAA 1 −1.0±0.5 a −0.6±0.4 ab 0.8±1.0 c −0.9±0.9 a 0.7±0.8 bc −0.9±0.6 a 0.01 <0.01 0.50
6 5.6±0.6 a * 4.9±0.5 ab * 4.7±0.4 b * 0.8±0.4 c 3.6±0.3 d * 1.6±0.3 e * <0.01 <0.01 <0.01
24 5.3±0.4 a * 5.3±0.6 a * 6.3±0.5 b * 1.9±0.5 c * 3.3±0.4 d * 3.0±0.6 d * <0.01 <0.01 0.47
Lf 1 0.7±0.2 a 0.1±0.3 bc −0.1±0.2 d 0.4±0.4 ab −0.7±0.4 d −0.6±0.3 cd 0.01 <0.01 0.53
6 2.6±0.4 a * 2.1±0.1 ab * 1.9±0.4 b * 0.0±0.5 c 1.6±0.2 b * 0.6±0.2 d <0.01 <0.01 0.02
24 3.9±0.5 a * 3.6±0.5 a * 4.1±0.5 a * 1.9±0.8 b * 2.4±0.4 b * 1.6±0.7 b * 0.36 <0.01 0.03
GM-CSF 1 0.6±0.2 a 0.0±0.4 ab −0.5±0.5 b 0.3±0.1 a 0.4±0.2 a 0.5±0.3 a 0.07 0.01 0.16
6 3.1±0.1 a * 3.9±0.2 b * 3.0±0.4 a * 0.0±0.3 c 1.6±0.2 d * 1.9±0.3 d * <0.01 0.71 0.04
24 0.4±0.6 ab 1.7±0.4 c * 0.5±0.4 a −1.4±0.3 d −0.7±0.4 bd −1.0±0.6 d 0.06 <0.01 0.39
COX-2 1 0.5±0.3 0.3±0.2 −0.1±0.4 0.6±0.3 −0.3±0.5 0.0±0.1 0.27 0.08 0.03
6 1.8±0.2 a * 1.8±0.4 ab * 1.5±0.3 abd * 0.2±0.1 c 1.1±0.1 bd * 1.0±0.4 d 0.06 <0.01 0.01
24 0.1±0.5 ab 0.8±0.2 b 0.8±0.2 b −0.6±0.3 a −0.3±0.2 a −0.4±0.4 a 0.58 0.59 <0.01
TLR2 1 0.0±0.3 a 0.6±0.3 a 0.3±0.9 a 0.6±0.3 a −0.3±0.3 a −0.2±0.5 a 0.57 0.05 0.95
6 2.7±0.3 a * 1.9±0.2 b * 2.0±0.3 b * 0.4±0.4 c 1.7±0.2 bd * 1.1±0.3 d * <0.01 <0.01 <0.01
24 2.1±0.4 ab * 2.2±0.6 a * 2.6±0.5 a * 0.9±0.4 c 1.5±0.3 bc * 1.1±0.6 c * 0.23 <0.01 0.51
a–e

Means within a row without common superscript letters differ (P<0.05).

*

Means differ significantly from negative control.

1

ΔΔCt values are normalized to negative controls and corrected for the two reference genes, GAPDH and ubiquitin.

2

IL-1β =  interleukin-1β; TNF-α =  tumor necrosis factor-α; IL-8 =  interleukin-8; RANTES =  regulated on activation, normal T cell expressed and secreted; SAA =  serum amyloid A; Lf =  lactoferrin; GM-CSF =  granulocyte-macrophage colony-stimulating factor; COX-2 =  cyclooxygenase-2; TLR2 =  toll-like receptor 2.

3

SLAT(−)  =  S. aureus latex agglutination test negative; SLAT(+)  =  S. aureus latex agglutination test positive.